SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 72 filers reported holding SERES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $263,000 | +52.0% | 38,325 | 0.0% | 0.00% | – |
| Q4 2018 | $173,000 | -70.3% | 38,325 | -50.0% | 0.00% | – |
| Q3 2018 | $582,000 | +74.8% | 76,650 | +97.8% | 0.00% | – |
| Q2 2018 | $333,000 | +17.3% | 38,758 | 0.0% | 0.00% | – |
| Q1 2018 | $284,000 | -27.7% | 38,758 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $393,000 | -36.8% | 38,758 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $622,000 | +42.0% | 38,758 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $438,000 | +1.4% | 38,758 | +1.2% | 0.00% | 0.0% |
| Q1 2017 | $432,000 | +6.1% | 38,308 | -6.8% | 0.00% | 0.0% |
| Q4 2016 | $407,000 | +15.6% | 41,101 | +43.5% | 0.00% | 0.0% |
| Q3 2016 | $352,000 | -57.7% | 28,639 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $832,000 | +145.4% | 28,639 | +124.7% | 0.00% | 0.0% |
| Q1 2016 | $339,000 | -24.2% | 12,747 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $447,000 | +73.9% | 12,747 | +47.1% | 0.00% | 0.0% |
| Q3 2015 | $257,000 | – | 8,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |